StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
76
This year
4
Publishing Date
2023 - 06 - 28
1
2023 - 06 - 15
1
2023 - 06 - 08
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 04 - 28
1
2023 - 03 - 06
1
2023 - 02 - 08
1
2023 - 01 - 13
1
2023 - 01 - 05
1
2023 - 01 - 04
1
2022 - 12 - 30
1
2022 - 12 - 15
1
2022 - 12 - 14
1
2022 - 11 - 30
1
2022 - 11 - 17
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 28
1
2022 - 09 - 16
1
2022 - 09 - 09
1
2022 - 09 - 08
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 25
1
2022 - 07 - 28
1
2022 - 07 - 13
1
2022 - 06 - 27
1
2022 - 06 - 23
1
2022 - 06 - 02
1
2022 - 05 - 27
1
2022 - 05 - 18
1
2022 - 05 - 05
1
2022 - 04 - 28
1
2022 - 04 - 26
1
2022 - 04 - 25
1
2022 - 04 - 12
1
2022 - 03 - 25
2
2022 - 03 - 16
1
2022 - 03 - 03
1
2022 - 03 - 01
1
2022 - 02 - 08
1
2022 - 01 - 11
1
2021 - 11 - 24
1
2021 - 11 - 04
1
2021 - 11 - 03
1
2021 - 09 - 22
1
2021 - 08 - 25
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 05
1
2021 - 07 - 12
1
2021 - 07 - 05
1
2021 - 06 - 25
1
2021 - 06 - 08
1
2021 - 06 - 06
1
2021 - 04 - 30
2
2021 - 04 - 13
1
2021 - 04 - 08
1
2021 - 03 - 04
1
Sector
Commercial services
1
Health services
2
Health technology
76
Manufacturing
11
Mining, quarrying, and oil and gas extraction
1
N/a
7
Professional, scientific, and technical services
1
Tags
America
67
Antibody
13
Application
12
Approval
21
Biosimilar
39
Breast
13
Cancer
106
Covid
17
Covid-19
12
Device
14
Diabetes
18
Diagnostics
19
Disease
76
Drug
116
Drug delivery
11
Earnings
21
Europe
17
Expansion
12
Expected
35
Eye
21
Fda
29
Financial
24
Financial results
13
Gene therapy
11
Global
229
Growing
47
Growth
263
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
20
Market
600
N/a
1119
Novartis
136
Patent
13
People
20
Pharma
17
Pharmaceuticals
17
Pipeline
12
Positive
20
Potential
13
Reach
34
Report
195
Research
129
Respiratory
15
Results
52
Risk
11
Sales
12
Sclerosis
13
Set
17
Study
17
T-cell
12
Technology
14
Therapeutics
115
Therapy
90
Treatment
138
Trial
25
Vaccine
16
Year
12
Entities
Abbott laboratories
11
Abbvie inc.
20
Acadia pharmaceuticals inc.
1
Aerie pharmaceuticals, inc.
1
Alcon inc.
1
Aldeyra therapeutics, inc.
1
Altimmune, inc.
1
Amgen inc.
9
Amicus therapeutics, inc.
1
Applied genetic technologies corporation
2
Arrival
2
Astellas pharma inc
5
Astrazeneca plc
14
Bausch health companies inc.
9
Baxter international inc.
2
Bio-techne corp
1
Biogen inc.
13
Biomarin pharmaceutical inc.
2
Bluebird bio, inc.
1
Boston scientific corporation
1
Brainstorm cell therapeutics inc.
5
Bristol-myers squibb company
9
Cellectis s.a.
1
Celyad oncology sa
2
Chemocentryx, inc.
1
Clovis oncology, inc.
1
Crispr therapeutics ag
1
Csl ltd
1
Danaher corporation
2
Denali therapeutics inc.
5
Eli lilly and company
10
Emmaus life sciences, inc.
1
Exagen inc.
1
Exelixis, inc.
1
Fresenius medical care ag & co. kgaa
1
Galapagos nv
1
Galectin therapeutics inc.
1
Galmed pharmaceuticals ltd.
1
Genfit s.a.
1
Gilead sciences, inc.
1
Glaukos corporation
1
Glaxosmithkline plc
19
Global blood therapeutics, inc.
1
Grifols sa
4
Grifols, s.a.
2
Incyte corporation
4
Intercept pharmaceuticals, inc.
1
Inventiva s.a.
1
Johnson & johnson
17
Madrigal pharmaceuticals, inc.
1
Medtronic plc
3
Mesoblast ltd
2
Novartis ag
76
Pfizer, inc.
5
Qiagen n.v.
2
Sanofi
28
Takeda pharmaceutical company limited
8
Teva pharmaceutical industries ltd
18
Thermo fisher scientific inc
2
Viatris inc.
10
Symbols
ABBV
65
ABOS
14
ABT
67
ACIU
21
ALDX
17
ALPMF
16
ALPMY
16
AMGN
26
ANVS
29
ATHA
24
ATHE
14
AVXL
24
AZN
34
AZNCF
23
BBIO
15
BDX
24
BEAM
15
BHC
20
BIIB
74
BIO
16
BIVI
32
BMY
22
BSX
16
CGTX
22
CNTG
23
CYTH
19
DHR
18
DNLI
15
FDMT
14
FNCTF
21
FOLD
20
GANX
21
GBT
33
GILD
20
GLAXF
24
GSK
39
HZNP
23
INCY
16
INMB
16
IONS
14
JNJ
108
LLY
89
MDT
30
MESO
24
NVO
18
NVS
76
NVSEF
61
PFE
28
PHG
15
REGN
16
RGLS
23
SAVA
26
SNY
179
SNYNF
130
TAK
33
TEVJF
36
TMO
47
VRTX
17
VTRS
16
ZVSA
18
Exchanges
Nasdaq
73
Nyse
76
Crawled Date
2023 - 07 - 10
1
2023 - 06 - 28
1
2023 - 06 - 15
1
2023 - 06 - 08
1
2023 - 05 - 23
1
2023 - 05 - 10
1
2023 - 04 - 28
1
2023 - 03 - 06
1
2023 - 02 - 09
1
2023 - 01 - 13
1
2023 - 01 - 05
1
2023 - 01 - 04
1
2022 - 12 - 30
1
2022 - 12 - 15
2
2022 - 11 - 30
1
2022 - 11 - 17
1
2022 - 11 - 10
1
2022 - 09 - 29
1
2022 - 09 - 28
1
2022 - 09 - 16
1
2022 - 09 - 09
1
2022 - 09 - 08
1
2022 - 09 - 06
1
2022 - 09 - 02
1
2022 - 08 - 25
1
2022 - 07 - 28
1
2022 - 07 - 13
1
2022 - 06 - 27
1
2022 - 06 - 23
1
2022 - 06 - 02
1
2022 - 05 - 27
1
2022 - 05 - 18
1
2022 - 05 - 05
1
2022 - 04 - 28
1
2022 - 04 - 26
1
2022 - 04 - 25
1
2022 - 04 - 12
1
2022 - 03 - 25
2
2022 - 03 - 16
1
2022 - 03 - 03
1
2022 - 03 - 01
1
2022 - 02 - 08
1
2022 - 01 - 11
1
2021 - 11 - 24
1
2021 - 11 - 04
1
2021 - 11 - 03
1
2021 - 09 - 22
1
2021 - 08 - 25
1
2021 - 08 - 24
1
2021 - 08 - 23
1
2021 - 08 - 05
1
2021 - 07 - 12
1
2021 - 07 - 05
1
2021 - 06 - 25
1
2021 - 06 - 08
1
2021 - 06 - 06
1
2021 - 04 - 30
2
2021 - 04 - 13
1
2021 - 04 - 08
1
2021 - 03 - 04
1
Crawled Time
00:00
2
01:00
7
02:00
1
03:00
4
04:20
1
07:00
1
09:00
1
10:00
3
11:00
4
12:00
8
12:20
3
12:30
1
13:00
2
13:20
1
14:00
2
15:00
3
15:30
1
16:00
4
17:00
4
18:00
6
19:00
3
20:00
6
21:00
3
22:00
2
23:00
2
23:09
1
Source
ir.voyagertherapeutics.com
1
www.biospace.com
7
www.globenewswire.com
3
www.prnewswire.com
65
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Disease
symbols :
Nvs
save search
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published:
2024-03-13
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-2.36%
|
O:
-0.23%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.91%
|
O:
-0.07%
H:
0.09%
C:
-0.7%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-7.28%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
-2.11%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
-6.55%
|
O:
0.59%
H:
0.01%
C:
-1.45%
drug
disease
report
research
global
market
Biosimilar Lymphocyte Modulator Global Market Report 2024 - Robust 10.6% CAGR Forecast, Amid Rising Autoimmune Disease Prevalence
Published:
2024-02-20
(Crawled : 03:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-4.1%
|
O:
2.81%
H:
0.0%
C:
-0.95%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-1.33%
|
O:
2.91%
H:
0.35%
C:
-0.38%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-11.82%
|
O:
-0.69%
H:
1.24%
C:
0.76%
disease
biosimilar
report
global
market
Hydroxychloroquine Market to Reach $2.86 Billion by 2028 Amidst Rising Demand for Autoimmune Disease Treatments
Published:
2024-02-13
(Crawled : 00:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
1.37%
|
O:
-2.71%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.2%
|
O:
-0.02%
H:
0.24%
C:
0.01%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
1.93%
|
O:
-1.1%
H:
0.0%
C:
0.0%
disease
reach
market
Global Cystic Fibrosis Lung Disease Research Report 2023: Analysis and Forecasts by Drug Type, Route of Administration, Distribution Channel, Region, and Country 2019-2029
Published:
2024-01-09
(Crawled : 17:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-9.65%
|
O:
-0.24%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-7.68%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
lung
drug
disease
report
distribution
fibrosis
research
global
Alzheimer's Disease Therapeutics Market size to grow by USD 5.41 billion from 2023-2028; North America to account for 39% of market growth - Technavio
Published:
2023-12-12
(Crawled : 20:00)
- prnewswire.com
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
28.85%
|
O:
-10.21%
H:
0.0%
C:
0.0%
GIKLY
|
$4.4
132.75%
150
|
Manufacturing
|
-38.8%
|
O:
2.92%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.7%
|
O:
0.71%
H:
0.88%
C:
0.85%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
10.64%
|
O:
-0.17%
H:
1.17%
C:
0.86%
DNLI
|
$15.55
-3.48%
-3.6%
940K
|
Health Technology
|
-16.49%
|
O:
2.9%
H:
8.82%
C:
8.56%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-22.43%
|
O:
0.09%
H:
2.58%
C:
2.52%
america
disease
alzheimer's
therapeutics
growth
market
Low-Density Lipoprotein Test Global Market Report 2023, By Product Type (LDL-C; LDL-P; LDL-B) , By Component, By Disease Type, By Distribution Channel and By End User
Published:
2023-12-11
(Crawled : 17:00)
- prnewswire.com
QGEN
|
$41.52
-0.88%
0.0%
820K
|
Health Technology
|
0.19%
|
O:
-0.02%
H:
0.9%
C:
0.77%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.66%
|
O:
0.75%
H:
0.55%
C:
0.27%
DHR
|
$250.41
-1.07%
-0.72%
3.3M
|
Health Technology
|
16.38%
|
O:
0.27%
H:
1.66%
C:
1.5%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
3.19%
|
O:
0.09%
H:
0.0%
C:
0.0%
QGEN
|
$41.52
-0.88%
0.0%
820K
|
Health Technology
|
0.19%
|
O:
-0.02%
H:
0.9%
C:
0.77%
disease
report
test
distribution
global
market
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published:
2023-12-06
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
10.33%
|
O:
1.64%
H:
0.0%
C:
-1.33%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
1.95%
|
O:
0.52%
H:
0.18%
C:
-0.43%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
13.52%
|
O:
-0.03%
H:
0.28%
C:
-0.41%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
26.79%
|
O:
0.99%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
17.27%
|
O:
0.26%
H:
0.0%
C:
0.0%
DNLI
|
$15.55
-3.48%
-3.6%
940K
|
Health Technology
|
-13.11%
|
O:
0.05%
H:
5.74%
C:
3.18%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-15.85%
|
O:
0.42%
H:
2.37%
C:
1.45%
disease
parkinson's
revenue
research
therapeutics
market
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive Therapeutics Inc., Bausch Health Companies Inc., Biogen Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 19:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
Email alert
Add to watchlist
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
BCLI
A
|
$0.5339
1.7%
1.67%
190K
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
disease
companies
health
therapeutics
market
Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight
Published:
2023-11-16
(Crawled : 22:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
13.94%
|
O:
-2.04%
H:
0.0%
C:
0.0%
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
1.89%
|
O:
1.01%
H:
0.0%
C:
-2.65%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
3.67%
|
O:
0.67%
H:
0.0%
C:
0.0%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
5.1%
|
O:
0.91%
H:
0.21%
C:
-0.01%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
0.1%
|
O:
0.78%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
19.74%
|
O:
1.05%
H:
1.44%
C:
1.15%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
9.84%
|
O:
2.58%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
2.17%
|
O:
1.42%
H:
0.0%
C:
0.0%
rare
disease
cell
eye
market
Global NASH Market to Soar to $2.71 Billion by 2023, Driven by Rising Prevalence of Silent Liver Disease
Published:
2023-11-11
(Crawled : 04:20)
- prnewswire.com
IVA
|
$3.28
-0.3%
-0.3%
13K
|
Health Technology
|
Email alert
Add to watchlist
GALT
|
$3.29
-2.66%
-2.74%
160K
|
Health Technology
|
Email alert
Add to watchlist
GNFT
|
$3.4449
-6.4%
3.5K
|
Health Technology
|
Email alert
Add to watchlist
ICPT
|
$19.0
-0.05%
4M
|
Health Technology
|
Email alert
Add to watchlist
IVEVF
|
$3.73
0%
1K
|
n/a
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
MDGL
|
$204.51
-6.35%
-6.78%
580K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
Email alert
Add to watchlist
GLMD
|
$0.3852
6.59%
6.18%
52K
|
Health Technology
|
Email alert
Add to watchlist
liver
disease
global
nash
market
Technological Advancements and Research Efforts Propel Neuromuscular Disease Therapeutics Market Growth
Published:
2023-10-27
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-10.45%
|
O:
-18.18%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.85%
|
O:
-3.68%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
26.36%
|
O:
0.0%
H:
0.17%
C:
-2.45%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.84%
|
O:
-0.23%
H:
0.08%
C:
-1.92%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
26.75%
|
O:
-0.59%
H:
0.15%
C:
-1.79%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.44%
|
O:
-15.73%
H:
0.0%
C:
0.0%
BCLI
A
|
$0.5339
1.7%
1.67%
190K
|
Health Technology
|
229.19%
|
O:
3.73%
H:
1.8%
C:
-4.19%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-19.87%
|
O:
-0.45%
H:
0.12%
C:
-2.28%
propel
disease
research
therapeutics
growth
market
Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026 | Market is driven by the increasing prevalence of chronic disease - Technavio
Published:
2023-10-24
(Crawled : 02:00)
- prnewswire.com
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-26.89%
|
O:
-0.4%
H:
1.18%
C:
0.17%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.4%
|
O:
-0.17%
H:
1.02%
C:
0.4%
BCLI
A
|
$0.5339
1.7%
1.67%
190K
|
Health Technology
|
215.66%
|
O:
-0.3%
H:
6.21%
C:
-8.0%
disease
cell
therapy
market
Inflammatory Bowel Disease Market to grow by USD 7,687.43 million from 2022 to 2027; The increasing demand for biologics and targeted therapies drives the market - Technavio
Published:
2023-08-16
(Crawled : 11:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
15.9%
|
O:
5.46%
H:
0.0%
C:
-2.87%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
11.1%
|
O:
-0.67%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
1.79%
|
O:
-0.99%
H:
1.45%
C:
1.36%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-3.64%
|
O:
-0.2%
H:
0.34%
C:
-0.26%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
16.96%
|
O:
-0.77%
H:
0.79%
C:
0.17%
BAX
|
$40.93
-0.22%
0.0%
2.2M
|
Health Technology
|
-3.14%
|
O:
-0.4%
H:
0.73%
C:
-0.24%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
11.81%
|
O:
0.56%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
1.6%
|
O:
-1.36%
H:
0.88%
C:
0.07%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-11.57%
|
O:
-1.33%
H:
0.0%
C:
0.0%
disease
market
US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease
Published:
2023-07-10
(Crawled : 12:00)
- biospace.com/
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
4.36%
|
O:
1.44%
H:
0.73%
C:
0.48%
leqvio
fda
disease
treatment
risk
novartis
heart
Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Report 2023: Increasing Prevalence of Lung Disease Drives Growth
Published:
2023-06-28
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
13.67%
|
O:
1.75%
H:
0.06%
C:
0.06%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-0.07%
|
O:
1.06%
H:
0.72%
C:
0.72%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-37.44%
|
O:
-1.98%
H:
0.0%
C:
-0.47%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.43%
|
O:
0.17%
H:
0.85%
C:
0.76%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
16.07%
|
O:
-1.21%
H:
1.17%
C:
0.91%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-0.02%
|
O:
-0.54%
H:
0.78%
C:
0.59%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-12.8%
|
O:
-1.86%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
-0.16%
|
O:
-0.83%
H:
0.89%
C:
0.68%
lung
disease
report
treatment
global
growth
market
Global Hearing Loss Disease Treatment Market Report 2023: Rising Prevalence of Hearing Loss Drives Growth
Published:
2023-06-15
(Crawled : 01:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.82%
|
O:
1.04%
H:
0.78%
C:
0.67%
disease
report
treatment
global
growth
market
Novartis premieres powerful new docuseries at Tribeca Festival to shine a light on debilitating skin disease
Published:
2023-06-08
(Crawled : 13:20)
- biospace.com/
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
17.13%
|
O:
1.32%
H:
0.0%
C:
-0.62%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.37%
|
O:
1.26%
H:
1.08%
C:
0.91%
disease
novartis
skin
DelveInsight Evaluates a Robust Dry Eye Disease Clinical Trial Pipeline as 60+ Influential Pharma Players to Set Foot in the Domain
Published:
2023-05-23
(Crawled : 15:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
13.64%
|
O:
-1.22%
H:
0.0%
C:
-0.62%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-1.87%
|
O:
0.74%
H:
0.0%
C:
-1.22%
GKOS
|
$100.93
-0.17%
0.0%
520K
|
Health Technology
|
70.49%
|
O:
-0.71%
H:
2.06%
C:
-1.05%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-3.07%
|
O:
-2.27%
H:
4.24%
C:
-2.21%
ALC
|
$79.57
-1.47%
0.0%
850K
|
Health Technology
|
-1.17%
|
O:
-0.51%
H:
0.02%
C:
-3.25%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
17.0%
|
O:
-0.31%
H:
0.26%
C:
-1.34%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.41%
|
O:
-0.01%
H:
0.0%
C:
0.0%
OCUL
|
News
|
$4.645
-7.1%
-7.64%
3.9M
|
Health Technology
|
-23.2%
|
O:
4.45%
H:
7.65%
C:
2.21%
GRFS
|
$6.4
-1.23%
-1.25%
960K
|
Health Technology
|
-28.08%
|
O:
0.78%
H:
0.0%
C:
-3.74%
ALDX
|
$3.93
0.51%
0.51%
570K
|
Health Technology
|
-59.94%
|
O:
0.0%
H:
2.36%
C:
0.61%
pharma
disease
pipeline
set
eye
trial
Global Gaucher's Disease Treatment Market Research Report 2023: Emerging Therapies, Clinical Trials, Treatments, Current Scenario Evaluation, Patient Profile
Published:
2023-05-10
(Crawled : 18:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
11.63%
|
O:
0.92%
H:
0.0%
C:
0.0%
TAK
|
News
|
$13.23
-1.12%
0.0%
920K
|
Health Technology
|
-21.41%
|
O:
-1.83%
H:
0.12%
C:
-3.06%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.6%
|
O:
-0.4%
H:
0.34%
C:
0.19%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-7.42%
|
O:
0.11%
H:
0.22%
C:
-0.52%
ABT
|
News
|
$106.89
-0.65%
-0.22%
5.1M
|
Health Technology
|
-2.8%
|
O:
-0.57%
H:
0.37%
C:
-0.01%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.01%
|
O:
-0.28%
H:
0.0%
C:
0.0%
disease
report
treatment
research
global
market
Global Rare Neurological Disease Treatment Market Report 2023: Promising Pipeline Drugs for Treatment of Rare Neurological Diseases Drives Growth
Published:
2023-04-28
(Crawled : 01:00)
- prnewswire.com
CSLLY
|
$90.71
3.3%
35K
|
n/a
|
-10.06%
|
O:
-1.61%
H:
0.55%
C:
0.52%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-3.69%
|
O:
-0.79%
H:
0.89%
C:
0.72%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-34.23%
|
O:
0.06%
H:
3.94%
C:
3.51%
rare
disease
report
pipeline
treatment
global
neurological
growth
market
← Previous
1
2
3
4
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.